Bibliographie (2530)
Spike in prescribing dexamethasone to Covid-19 patients may do more harm than good
mardi, 03 novembre 2020 06:19 Écrit par Zouhair SouissiSpike in prescribing dexamethasone to Covid-19 patients may do more harm than good – STAT
The post Spike in prescribing dexamethasone to Covid-19 patients may do more harm than good appeared first on Links Medicus.
Opinion – Hydroxychloroquine: A tale of overzealous optimism and patient harm
mardi, 03 novembre 2020 06:19 Écrit par Zouhair SouissiHydroxychloroquine: A tale of overzealous optimism and patient harm – First10EM
The post Opinion – Hydroxychloroquine: A tale of overzealous optimism and patient harm appeared first on Links Medicus.
Perspective: A series of disappointing results of immune-based therapies for COVID-19
mardi, 03 novembre 2020 06:19 Écrit par Zouhair SouissiA Series of Disappointing Results of Immune-Based Therapies for COVID-19 – HIV and ID Observations
The post Perspective: A series of disappointing results of immune-based therapies for COVID-19 appeared first on Links Medicus.
Updated clinical guide for the critical care management of adults with COVID-19
mardi, 03 novembre 2020 06:19 Écrit par Zouhair SouissiClinical guide for the management of critical care for adults with COVID-19 during the Coronavirus pandemic – Intensive Care Society
The post Updated clinical guide for the critical care management of adults with COVID-19 appeared first on Links Medicus.
Regeneron: Independent committee recommends holding trial enrollment in hospitalized patients with high oxygen requirements
lundi, 02 novembre 2020 06:02 Écrit par Zouhair SouissiREGN-COV2 independent data monitoring committee recommends holding enrollment in hospitalized patients with high oxygen requirements and continuing enrollment in patients with low or no oxygen requirements – Regeneron Commentary on Twitter More potential evidence against antibody drugs late in course of #COVID19: Regeneron says independent cmte has recommended not enrolling pts on high oxygen […]
The post Regeneron: Independent committee recommends holding trial enrollment in hospitalized patients with high oxygen requirements appeared first on Links Medicus.
CDC Report: Transmission of SARS-COV-2 infections in households
lundi, 02 novembre 2020 06:02 Écrit par Zouhair SouissiTransmission of SARS-COV-2 Infections in Households — Tennessee and Wisconsin, April–September 2020 – CDC Morbidity and Mortality Weekly Report Commentaries: A new CDC study suggests roughly 50% of people living with someone who has COVID-19 get it — usually in less than 5 days – Business Insider AND Household spread of Covid-19 is common and […]
The post CDC Report: Transmission of SARS-COV-2 infections in households appeared first on Links Medicus.
Videos in clinical medicine: Percutaneous Tracheostomy
vendredi, 30 octobre 2020 09:57 Écrit par Zouhair SouissiPercutaneous Tracheostomy – New England Journal of Medicine
The post Videos in clinical medicine: Percutaneous Tracheostomy appeared first on Links Medicus.
The ‘very, very bad look’ of remdesivir, the first FDA-approved COVID-19 drug
vendredi, 30 octobre 2020 09:57 Écrit par Zouhair SouissiThe ‘very, very bad look’ of remdesivir, the first FDA-approved COVID-19 drug – Science Commentaries on Twitter Remdesivir, despite failing in Solidarity trial, received FDA approval without input from outside advisory group. EU cut pricing deal with Gilead without knowing Solidarity data. @kakape and I explain in "The ‘very, very bad look’ of remdesivir" […]
The post The ‘very, very bad look’ of remdesivir, the first FDA-approved COVID-19 drug appeared first on Links Medicus.
Report: COVID-19 infection fatality ratio estimates from seroprevalence
vendredi, 30 octobre 2020 09:57 Écrit par Zouhair SouissiReport 34 – COVID-19 Infection Fatality Ratio Estimates from Seroprevalence – Imperial College London Full report: COVID-19 Infection Fatality Ratio: Estimates from Seroprevalence Commentary on Twitter UPDATE #COVID19 Infection Fatality Ratio (IFR): ➡️1.15% IFR (high income countries) ➡️0.23% IFR (low income countries)➡️0.1% IFR (under 40 year olds)➡️5.6% IFR (over 80 year olds)➡️Risk of COVID19 […]
The post Report: COVID-19 infection fatality ratio estimates from seroprevalence appeared first on Links Medicus.
Randomized trial: Osimertinib in resected EGFR-Mutated non–small-cell lung cancer
jeudi, 29 octobre 2020 12:25 Écrit par Zouhair SouissiOsimertinib in Resected EGFR-Mutated Non–Small-Cell Lung Cancer – New England Journal of Medicine
The post Randomized trial: Osimertinib in resected EGFR-Mutated non–small-cell lung cancer appeared first on Links Medicus.
